Press Releases March 29, 2026 08:00 PM

Arbor Realty Trust Declares Preferred Stock Dividends

Arbor Realty Trust Announces Dividend Payments on Multiple Series of Preferred Stock

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
ABR

Arbor Realty Trust, Inc. declared dividends for its Series D, E, and F cumulative redeemable preferred stocks, payable on April 30, 2026. The dividend payments reflect accrued amounts and reaffirm the company's commitment to its preferred shareholders amid its ongoing real estate finance operations.

Arbor Realty Trust Declares Preferred Stock Dividends
ABR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Declared preferred stock dividends for Series D, E, and F, payable April 30, 2026.
  • Arbor specializes in multifamily, single-family rental portfolios, and commercial real estate lending nationwide.
  • Maintains a strong presence as a Fannie Mae DUS lender and Freddie Mac Optigo Seller/Servicer, with multi-billion-dollar servicing portfolio.

UNIONDALE, N.Y., March 30, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced that its Board of Directors has declared cash dividends on the Company's Series D, Series E, and Series F cumulative redeemable preferred stock of $0.3984375, $0.390625, and $0.390625 per share, respectively. The Series D, E, and F preferred stock dividends reflect accrued dividends from January 30, 2026 through April 29, 2026. The dividends are payable on April 30, 2026 to preferred stockholders of record on April 15, 2026.

About Arbor Realty Trust, Inc.

Arbor Realty Trust, Inc. (NYSE: ABR) is a nationwide real estate investment trust and direct lender, providing loan origination and servicing for multifamily, single-family rental (SFR) portfolios, and other diverse commercial real estate assets. Headquartered in New York, Arbor manages a multibillion-dollar servicing portfolio, specializing in government-sponsored enterprise products. Arbor is a leading Fannie Mae DUS® lender and Freddie Mac Optigo® Seller/Servicer, and an approved FHA Multifamily Accelerated Processing (MAP) lender. Arbor’s product platform also includes bridge, CMBS, mezzanine and preferred equity loans. Rated by Standard and Poor’s and Fitch Ratings, Arbor is committed to building on its reputation for service, quality and customized solutions with an unparalleled dedication to providing our clients excellence over the entire life of a loan.

Safe Harbor Statement  

Certain items in this press release may constitute forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations and beliefs and are subject to a number of trends and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Arbor can give no assurance that its expectations will be attained. Factors that could cause actual results to differ materially from Arbor’s expectations include, but are not limited to, changes in economic conditions generally, and the real estate markets specifically, continued ability to source new investments, changes in interest rates and/or credit spreads, and other risks detailed in Arbor’s Annual Report on Form 10-K for the year ended December 31, 2025 and its other reports filed with the SEC. Such forward-looking statements speak only as of the date of this press release. Arbor expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Arbor’s expectations with regard thereto or change in events, conditions, or circumstances on which any such statement is based.

Contact:
Arbor Realty Trust, Inc.
Investor Relations
516-506-4200
[email protected]  



Risks

  • Exposure to changes in economic conditions and real estate market fluctuations which can impact financial performance.
  • Interest rate and credit spread volatility affecting lending and investment returns.
  • Ability to source new investments and maintain portfolio quality could be hindered under uncertain market conditions.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026